Tag Archives: Ebola

FDA Approves Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) Antibody Cocktail for Ebola (Zaire Ebolavirus)

TARRYTOWN, N.Y., Oct. 14, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the U.S. Food and Drug Administration (FDA) approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including newborns of mothers who have tested positive for the infection. “We are… Read More »

From fighting Ebola to trying to wipe out polio, U.S. pullout from WHO will have tangible impact: experts

Ebola is a truly horrible disease, but the 2018-19 outbreak of the virus in the Democratic Republic of Congo was particularly chaotic, as health workers tried to save lives amid an ongoing civil war. There could have been even more disarray, says Dr. Srinivas Murthy, had the World Health Organization not overseen the various medical… Read More »